Medication use in early pregnancy-prevalence and determinants of use in a prospective cohort of women

Pharmacoepidemiology and Drug Safety
Brian J ClearyDeirdre J Murphy

Abstract

To examine the extent, nature and determinants of medication use in early pregnancy. We reviewed early pregnancy medication use, as reported to a midwife at the booking interview, in women delivering between 2000 and 2007 in a large maternity hospital in Dublin, Ireland (n = 61 252). Excluding folic acid, at least one medication was reported in 23 989 (39.2%) pregnancies. Over the counter (OTC) medications were reported in 11 970 (19.5%) pregnancies, illicit drugs or methadone in 545 (0.9%) and herbal medicines/supplements in 352 (0.58%). FDA category D and X medications were reported by 1532 (2.5%) and 1987 (3.2%) women. Asthma, depression and hypertension were among the most commonly reported chronic medical disorders. Medications with potential for foetal harm were reported by 86 (15.7%) women treated for depression and 68 (20%) women treated for hypertension. Factors associated with reporting the use of medications with potential for foetal harm included unplanned pregnancy (adjusted odds ratio [aOR] 1.31, 95% confidence interval [CI] 1.12-1.52), booking at less than 12 weeks gestation (aOR 1.83, 95%CI 1.58-2.13), being above 25 years of age, unemployed (aOR 2.58, 95%CI 2.03-3.29), nulliparous (aOR 1.41; 95%CI 1.22-1.63), s...Continue Reading

References

Jun 1, 1985·Journal of Epidemiology and Community Health·R Balarajan, M McDowall
Jan 1, 1995·Obstetrics and Gynecology·L Raman-WilmsG Koren
Feb 1, 1996·Drug Safety : an International Journal of Medical Toxicology and Drug Experience·R SannerstedtE Ridley
Nov 30, 2000·Lancet·I LacroixJ L Montastruc
Aug 16, 2001·Epidemiology·C OlesenUNKNOWN EuroMAP Group
Aug 15, 2002·Hypertension in Pregnancy : Official Journal of the International Society for the Study of Hypertension in Pregnancy·Helen BaylissD G Beevers
Sep 11, 2002·Obstetrics and Gynecology·W Y Lo, J M Friedman
Apr 18, 2003·European Journal of Clinical Pharmacology·Heli MalmUNKNOWN Finnish Register-Based Study
Dec 13, 2003·Archives of Disease in Childhood·A M Weindling
Feb 20, 2004·Journal of Human Hypertension·B WilliamsUNKNOWN British Hypertension Society
May 29, 2004·European Journal of Clinical Pharmacology·J HeadleyUNKNOWN ALSPAC Study Team
Sep 3, 2004·American Journal of Obstetrics and Gynecology·Susan E AndradeRichard Platt
Oct 14, 2004·European Journal of Clinical Pharmacology·Veronika Egen-Lappe, Joerg Hasford
Jan 8, 2005·The Journal of Allergy and Clinical Immunology·UNKNOWN National Heart, Lung, and Blood Institute, UNKNOWN National Asthma Education and Prevention Program Asthma and Pregnancy Working Group
Oct 6, 2005·Birth Defects Research. Part A, Clinical and Molecular Teratology·Robert L Brent
Apr 6, 2006·Pharmacoepidemiology and Drug Safety·Susan E AndradeJerry H Gurwitz
Apr 28, 2006·BJOG : an International Journal of Obstetrics and Gynaecology·M K BakkerL T W De Jong-Van Den Berg
May 16, 2006·Pharmacoepidemiology and Drug Safety·Euni LeeZhenyi Xue
Jun 9, 2006·The New England Journal of Medicine·William O CooperWayne A Ray
Aug 31, 2006·Pharmacoepidemiology and Drug Safety·Sonia Hernández-Díaz
Jan 12, 2007·Birth Defects Research. Part A, Clinical and Molecular Teratology·Bengt A J Källén, Petra Otterblad Olausson
Jul 31, 2007·The Journal of Allergy and Clinical Immunology·Rachel EnriquezTina V Hartert
Aug 1, 2007·Birth Defects Research. Part A, Clinical and Molecular Teratology·UNKNOWN Public Affairs Committee of the Teratology Society
Oct 24, 2007·British Journal of Clinical Pharmacology·Marian K BakkerLolkje T W de Jong van den Berg
Jan 18, 2008·Pharmacoepidemiology and Drug Safety·Susan E AndradeRichard Platt
Aug 8, 2008·European Journal of Clinical Pharmacology·Joshua J GagneJoseph S Gonnella

❮ Previous
Next ❯

Citations

Dec 23, 2011·European Journal of Clinical Pharmacology·Eivind YstromHedvig Nordeng
Apr 25, 2012·Archives of Women's Mental Health·Hedvig NordengMalin Eberhard-Gran
Feb 7, 2013·International Journal of Clinical Pharmacy·Marina OdalovicLjiljana Tasic
Dec 29, 2011·Clinical & Developmental Immunology·Yang-Ching ChenYungling Lee
May 10, 2013·Environmental Health : a Global Access Science Source·Ann Z Bauer, David Kriebel
Apr 18, 2013·PloS One·Rachel A CharltonCorinne S de Vries
May 25, 2011·Clinical Epidemiology·Anne-Mette Bay BjørnVera Ehrenstein
Jun 15, 2013·Drug and Therapeutics Bulletin
Sep 20, 2011·Gynécologie, obstétrique & fertilité·C Hurault-DelarueC Damase-Michel
May 6, 2015·Acta Obstetricia Et Gynecologica Scandinavica·Anne S ErsbøllHanne K Hegaard
Mar 10, 2016·Pharmacoepidemiology and Drug Safety·Kristen A JohnsonEnrique F Schisterman
Jun 29, 2015·The Journal of Allergy and Clinical Immunology. in Practice·Rachel A CharltonKourtney J Davis
Oct 16, 2014·BJOG : an International Journal of Obstetrics and Gynaecology·I M ZomerdijkB H Stricker
Jul 12, 2014·Thérapie·Alice PanchaudNicolas Widmer
Oct 10, 2013·Human Reproduction·Marleen M H J van GelderLolkje T W de Jong-van den Berg
Nov 6, 2018·Pharmacoepidemiology and Drug Safety·Sarah DonaldLianne Parkin
Apr 12, 2016·Breathe·Vanessa E Murphy
Jul 26, 2019·Pharmacoepidemiology and Drug Safety·Michael CeulemansVeerle Foulon
Apr 25, 2019·The Journal of Asthma : Official Journal of the Association for the Care of Asthma·Olufemi O DesaluAlakija K Salami
Jun 22, 2017·Journal of Psychosomatic Obstetrics and Gynaecology·Necip GiritH Alper Tanriverdi
Jun 7, 2017·BMC Pregnancy and Childbirth·Fantahun MollaWondim Melkam
Apr 7, 2018·Chronic Respiratory Disease·Wanis H IbrahimAzdin A Ibrahim
Jun 20, 2018·PloS One·Monica NavaroUNKNOWN Collaborative Working Group
Sep 25, 2018·Drug Safety : an International Journal of Medical Toxicology and Drug Experience·Saskia VorstenboschEugène van Puijenbroek
Jul 3, 2020·SAGE Open Medicine·Yohanes AyeleFisseha Bonja Geleto
Feb 6, 2020·The Journal of Allergy and Clinical Immunology. in Practice·Cristina LongoLucie Blais
May 31, 2021·Revue des maladies respiratoires·T Stoup, C Chenivesse
Feb 15, 2020·Revue des maladies respiratoires·C RaherisonUNKNOWN groupe de travail 'Femmes et poumons' de la SPLF
Dec 1, 2010·Current Opinion in Psychiatry

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.